International Isotopes raises $19.5 million:
This article was originally published in Clinica
Executive Summary
International Isotopes has closed a two-stage private equity financing, raising $19.5 million. The company says that the proceeds, together with an expected increase in product revenues over the next six months, should provide it with a positive cash flow by the end of the year. International Isotopes, of Denton, Texas, has just begun commercial production of Iodine-125 brachytherapy seeds, used for the treatment of prostate cancer. The product is in clinical development for treating tumours in the breast, eye and oesophagus. The company plans to begin commercial shipments of six radioisotopes and radiochemicals during the third and fourth quarter.